Joseph S. Friedberg, MD, Appointed as Division Head of Thoracic Surgery; Shamus Carr, MD, Named Associate Chief

For immediate release: September 25, 2014

Renowned surgeon-scientists to bolster Greenebaum Cancer Center's Thoracic Surgical Oncology Program

The University of Maryland School of Medicine has announced the appointments of two internationally-recognized surgeon-scientists to lead its thoracic surgery and research programs. Joseph S. Friedberg, MD, will join the institution as head of its Division of Thoracic Surgery and the Charles Reid Edwards Professor of Surgery. He will also serve as Thoracic-Surgeon-in-Chief of the University of Maryland Medical System. Shamus Carr, MD, will serve as associate chief of the Division of Thoracic Surgery. The appointments will elevate the university’s thoracic surgery program and further strengthen the University of Maryland Marlene and Stewart Greenebaum Cancer Center’s position as a clinical and research leader in the treatment of thoracic cancers.

Within the Greenebaum Cancer Center, Drs. Friedberg and Carr will join the multi-disciplinary care team and serve as surgical experts on thoracic cancer cases, determining the best course of treatment for each patient. Their expertise will complement that of other thoracic cancer specialists within the center, including medical oncologist Martin Edelman, MD, a highly-regarded lung cancer expert who recently returned to the center as head of Solid Tumor Oncology in the Division of Hematology/Oncology.

“Dr. Joseph Friedberg and Dr. Shamus Carr bring with them extensive clinical experience and innovative research portfolios,” says Kevin J. Cullen, MD, director of the Greenebaum Cancer Center. “Their appointments elevate our thoracic cancer program as a regional and even national leader for the treatment of advanced disease.”

The longtime research collaborators are foremost experts in the treatment of mesothelioma, a relatively uncommon form of cancer of the lungs, abdomen, heart and chest cavity. In addition to his clinical work in this area, Dr. Friedberg is exploring innovative treatments for the diseaseand is testing photodynamic therapy for mesothelioma ina clinical trial sponsored by the National Institutes of Health. He will continue this important work at the University of Maryland.

Dr. Friedberg is currently a professor of surgery at the University of Pennsylvania’s Perelman School of Medicine in Philadelphia, and Dr. Carr is an assistant professor of surgery at the University of Utah School of Medicine in Salt Lake City.

Read the announcement on Dr. Friedberg and Dr. Carr’s appointments on the UM School of Medicine website.